246 related articles for article (PubMed ID: 33191805)
1. The effect of illness perception on life quality in psoriasis patients.
Solmaz N; Ilhan N; Bulut HM
Psychol Health Med; 2021 Sep; 26(8):955-967. PubMed ID: 33191805
[TBL] [Abstract][Full Text] [Related]
2. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
3. The relationship between quality of life and the severity of psoriasis in Turkey.
Çakmur H; Derviş E
Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
[TBL] [Abstract][Full Text] [Related]
4. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.
Silva MF; Fortes MR; Miot LD; Marques SA
An Bras Dermatol; 2013; 88(5):760-3. PubMed ID: 24173182
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
Mattei PL; Corey KC; Kimball AB
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
[TBL] [Abstract][Full Text] [Related]
7. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
[TBL] [Abstract][Full Text] [Related]
8. Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.
Khawaja AR; Bokhari SM; Tariq R; Atif S; Muhammad H; Faisal Q; Jafferany M
Prim Care Companion CNS Disord; 2015; 17(3):. PubMed ID: 26644955
[TBL] [Abstract][Full Text] [Related]
9. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
[TBL] [Abstract][Full Text] [Related]
11. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
[TBL] [Abstract][Full Text] [Related]
12. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
[TBL] [Abstract][Full Text] [Related]
13. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
14. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
[TBL] [Abstract][Full Text] [Related]
15. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis.
Maul JT; Maul LV; Didaskalu JA; Valenzuela F; Romiti R; Peterson H; Korouri E; Novoa F; Oon HH; Zheng M; Wu JJ; Thyssen JP; Egeberg A; Armstrong AW; Nielsen ML
Acta Derm Venereol; 2024 Mar; 104():adv20329. PubMed ID: 38470165
[TBL] [Abstract][Full Text] [Related]
16. PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study.
Cozzani E; Linder D; Burlando M; Gallo F; Sampogna F; Bruzzone M; Tacchino C; Drago F; Parodi A
Eur J Dermatol; 2018 Jun; 28(3):332-337. PubMed ID: 29789272
[TBL] [Abstract][Full Text] [Related]
17. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Disease Activity and Quality of Life of Patients with Psoriasis after Narrow-band Ultraviolet B Therapy.
Dourmishev LA; Lyubomirova K
Folia Med (Plovdiv); 2020 Mar; 62(1):89-93. PubMed ID: 32337912
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
Schmitt J; Küster D
Arch Dermatol Res; 2015 Jul; 307(5):451-3. PubMed ID: 25940274
[TBL] [Abstract][Full Text] [Related]
20. Moderate Psoriasis: A Proposed Definition.
Llamas-Velasco M; de la Cueva P; Notario J; Martínez-Pilar L; Martorell A; Moreno-Ramírez D
Actas Dermosifiliogr; 2017 Dec; 108(10):911-917. PubMed ID: 28823420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
